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There is a possibility that many ofthe hun-
dreds ofchemicals that produce allergic con-
tact dermatitis (ACD) in humans might be
environmental carcinogens (1). Most con-
tact sensitizers are electrophiles (2). They are
Table 1. SAL+,CHO+ NTP compounds
Chemical
Allyl glycidyl ether
2-Aminoanthroquinone
1-Amino-2-methylanthraquinone
2-Amino-4-nitrophenol
2-Amino-5-nitrophenol
4-Amino-2-nitrophenol
2-Amino-5-nitrothiazole
5-Azacytidine
Azinphosmethyl
p-Benzoquinone dioxime
1,2,3-Benzotriazole
2-Biphenylamine hydrochloride
Bis(2-chloro-1-methylethyl) ether
Captan
Chlorinated trisodium phosphate
4-(Chloroacetyl)-acetanalide
p-Chloroanaline
2-Chloroethanol
2-Chloromethylpyridine hydrochloride
3-Chloromethylpyridine hydrochloride
4-Chloro-m-phenylenediamine
4-Chloro-o-phenylenediamine
2-Chloro-p-phenylenediamine
Chloropicrin
(continued on nextpage)
CAS
106-92-3
117-79-3
082-28-0
099-57-0
121-88-0
119-34-6
121-66-4
320-67-2
086-50-0
105-11-3
095-14-7
2185-92-4
108-60-1
133-06-2
56802-99-4
140-49-8
106-47-8
107-07-3
6959-47-3
6959-48-4
5131-60-2
95-83-0
61702-44-1
76-06-2
able to attach themselves as adducts on
macromolecules, specifically proteins, as the
basis for the induction of ACD.
Electrophilicity is also a common character-
istic of genotoxic carcinogens (3); adducts
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Route
Inhalation
Feed
Feed
Gavage
Gavage
Feed
Feed
Intraperitoneal
Feed
Feed
Feed
Feed
Gavage
Feed
Gavage
Feed
Gavage
Dermal
Gavage
Gavage
Feed
Feed
Feed
Gavage
form on DNA as well as on protein, result-
ing in genetic damage and the initiation of
the carcinogenic process. Genotoxic carcino-
gens have been shown to be contact sensitiz-
ers in the skin of the guinea pig (4) and in
the mouse ear (5). A number of chemicals
known to be contact sensitizers for humans
(6) are found in the NIH list ofcarcinogens
(7 these include nickel, chromium, benzi-
dine, beryllium, cadmium, coal tar,
epichlorohydrin, butyl hydroxyanisole,
DDT, p-dichlorobenzene, dimethylaminoa-
zobenzene, formaldehyde, hydrazine, lin-
dane, 4,4'-methylenedianaline, thiourea,
and toluene 2,4-diisocyanate. Hence, car-
cinogens can be contact sensitizers and con-
tact sensitizers can be carcinogens. While
contact sensitization is a skin response, it is
clear from the above examples that cancer
induction by agents that are contact sensitiz-
ers can occur internally by a variety ofexpo-
sure routes not involving the skin.
Given the possibility that contact sensi-
tization might be a practical means ofiden-
tifying previously unsuspected environmen-
tal carcinogens, we wondered what pattern
oftumorigenic responses would be obtained
ifa sample ofthe many hundreds ofknown
human contact sensitizers were subjected to
conventional genotoxicity and rodent can-
cer bioassays. As an indirect approach to the
question, we examined the NTP carcino-
genesis and genotoxicity bioassay series for
the presence ofcontact sensitizers and their
tumorigenic effects.
The NTP series encompasses hundreds
of chemicals that have been subjected to
highly standardized and carefully moni-
tored bioassays. The chemicals were recom-
mended for study mainly by federal health
and environmental agencies without regard
to their ability to produce ACD. We exam-
ined several hundred NTP bioassays and
found that they included a number of
chemicals, both genotoxic and nongenotox-
ic, that are known to be human contact
sensitizers. The essential finding was that
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Table1.(continued)
Chemical CAS
C.l. Acid orange 3
C.l. Disperse blue 1
Coumarin
m-Cresidine
p-Cresidine
Cupferron
Cytembena
2,4-Diaminoanisole sulfate
2,4-Diaminotoluene
1,2-Dibromo-3-chloropropane
1,2-Dibromoethane
2,3-Dibromo-1-propanol
1,2-Dichloroethane
2,6-Dichloro-p-phenylenediamine
1,2-Dichloropropane
Dichlorvos
Diglycidyl resorcinol ether
Dimethoxane
2,4-Dimethoxyaniline hydrochloride
3,3'-Dimethoxybenzidine-4,4'
diisocyanate
Dimethyl hydrogen phosphite
1,2-Epoxybutane
Glycidol
HC Blue 1
HC Red 3
Hydrazobenzene
8-Hydroxyquinoline
lodinated glycerol
Lasiocarpine
4,4'-Methylenedianaline
2-Methyl-1-nitroanthraquinone
Michler's ketone
1,5-Napthalenediamine
N-(1-Napthyl)ethylenediamine
dihydrochloride
5-Nitroacenaphthene
p-Nitroanaline
o-Nitroanisole
4-Nitroanthranilic acid
6-Nitrobenzimidazole
p-Nitrobenzoic acid
Nitrofurantoin
Nitrofurazone
1-Nitronapthalene
2-Nitro-p-phenylenediamine
3-Nitroproprionic acid
p-Nitrosodiphenylamine
5-Nitro-o-toluidine
4,4'-Oxydianiline
Phenazopyridine hydrochloride
Phenoxybenzamine hydrochloride
p-Phenylenediamine
dihydrochloride
1,2-Propylene oxide
Quercetin
Selenium sulfide
Tetranitromethane
4,4'-Thiodianaline
2,6-Toluenediamine dihydrochloride
2,5-Toluenediamine sulfate
1,2,3-Trichloropropane
2,4,5-Trimethylanaline
Trimethylphosphate
4-Vinyl-1-cyclohexene diepoxide
Ziram
6373-74-6
2475-45-8
91-64-5
102-50-1
120-71-8
135-20-6
21739-91-3
615-05-4
90-80-7
96-12-8
106-93-4
96-13-9
107-06-2
609-20-1
78-87-5
62-73-7
101-90-6
828-00-2
54150-69-5
91-93-0
868-85-9
106-88-7
556-52-5
2784-94-3
2871-01-4
122-66-7
148-24-3
5634-39-9
303-34-4
13552-44-8
129-15-7
90-94-8
2243-62-1
1465-25-4
602-87-9
100-01-6
91-23-6
619-17-0
94-52-0
62-23-7
67-20-9
59-87-0
86-57-7
5307-14-2
504-88-1
156-10-5
99-55-8
101-80-4
136-40-3
63-92-3
624-18-0
75-56-9
117-39-5
7446-34-6
509-14-8
139-65-1
15481-70-6
6369-59-1
96-18-4
137-17-7
512-56-1
106-87-6
137-30-4
CS RFBa Tumorscoreb
+ 2 1
+ 2 2
+ 1 4
2 (2)
2 8
2 12
5 2
2 6
7 4
7 9
7 13
4 30
4 8
2 2
2 2se
2 4
3 4
7 0
2 0
2 8
Route
Gavage
Feed
Gavage
Gavage
Feed
Feed
Intraperitoneal
Feed
Feed
Inhalation
Inhalation
Dermal
Gavage
Feed
Gavage
Gavage
Gavage
Gavage
Feed
Gavage, feed
8 2 Gavage
2 4 Inhalation
2 24 Gavage
2 3 Feed
2 0 Gavage
2 5 Feed
2 0 Feed
2 4se Gavage
7 (5) Feed
2 10 Water
2 4 Feed
2 4 Feed
2 6 Feed
2 0 Feed
2 8 Feed
2 0 Gavage
2 10 Feed
2 0 Feed
2 2 Feed
2 1 Feed
2 6 Feed
4 3 Feed
2 0 Feed
2 1 Feed
1 2 Gavage
2 2 Feed
2 4 Feed
2 9 Feed
5 3 Feed
5 4 Intraperitoneal
+ 2 0 Feed
2 4 Inhalation
3 Ise Feed
5 4 Dermal
1 4 Inhalation
7 11 Feed
+ 2 0 Feed
2 0 Feed
2 19 Gavage
2 4 Feed
1 2 Gavage
1 5 Dermal
+ 1 2 Feed
Abbreviations: SAL, Ames Salmonella mutagenesis assay; CHO, Chinese hamster ovary cell assay for chro-
mosomal abnormalities; CAS, Chemical Abstracts Registry number; CS, contactsensitization.
aRFB-primary rationale forthe bioassay as follows: 1, widespread use; 2, structural relation with known car-
cinogen ormutagen;3,inadequate previous study;4, representative of a structural class; 5,drug with prolonged
exposure; 6, potential use as an antineoplastic drug; 7, preexisting evidence ofcarcinogenicity; and 8, potential
warfare agent
bTumor score isthe numberofdifferent organsthatshowed tumor induction in mice and rats ofboth sexes; paren-
theses indicatethe numberoftumorsitesthatwere obtained onlyon asingle species; se-tumorresponses indicate
thosethatwere classified assome evidence in contrasttothe strongerdesignation ofclearevidence.
about half of the contact sensitizers were
positive in the cancer bioassay, supporting
the possibility that contact sensitizers
might be an important group of environ-
mental carcinogens.
Results
The NTP technical reports were the only
source ofbioassay data used in this analysis,
and only those chemicals that had both
genotoxicity and carcinogenesis bioassays
were used. The lists ofchemicals were pro-
vided by the NTP on the basis ofwhat had
been completed and published as technical
reports by May 1996; the chemicals were
stratified according to the results oftheAmes
Salmonella assay (SAL) for mutagenicity and
the Chinese hamster ovary cell (CHO) assay
for chromosomal damage. The Ames assay
was selected because it is regarded as the
most predictive index ofcarcinogenicity (8).
There were other tests ofmutagenicity, e.g.,
on mammalian cells, thatwere not used con-
sistently in the bioassay series and were not
included in this analysis. The CHO assay
was chosen on the possibility that contact
sensitizers, by being interactive with protein,
might cause genotoxicity by indirect mecha-
nisms. Someofthe chemicals had more repe-
titions ofgivengenotoxicity tests than others.
Chemicals were identified as contact
sensitizers by the use of a list of 384 such
agents in one dermatology text (6) and
confirmed by another (9), with the addi-
tion ofparathion. There is no formally rec-
ognized registry of contact sensitizers with
standardized inclusion criteria.
Tables 1-4 list the chemicals according
to the four combinations of the two geno-
toxicity indices: SAL+,CHO+; SAL+,CHO-;
SAL-,CHO+; and SAL-,CHO-. These tables
indicate which chemicals are contact sensi-
tizers, the rationale for their being selected
for bioassay, and the route of exposure.
About 90% ofthe routes of exposure were
via the gastrointestinal tract in the total
NTP sample: feed (56%), gavage (33%),
and drinking water (2%). The other routes
of exposure included intraperitoneal injec-
tion (1%), dermal application (2%), and
inhalation (6%). There were no differences
in the routes ofexposure according to geno-
toxicity or contact sensitization.
Tumorigenicity is also indicated in
Tables 1-4. Each chemical was effectively
bioassayed four times with 50 animals each,
i.e., in male and female rats and mice. We
analyzed the data on the basis of the com-
bined number of organs in the four test
groups that had a statistically significant
increase in tumor formation; the different
tumor types within any given organ were
lumped together, e.g., bile duct and hepato-
cellular tumors in the liver. The tumor
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Table2. SAL+,CH0+ NTP compounds
Chemical CAS CS RFBa Tumorscoreb Route
Azobenzene 103-33-3 2 2 Feed
3-Amino-4-ethoxyacetanalide 17026-81-2 2 1 Feed
3-Amino-9-ethylcarbazole hydrochloride 132-32-1 2 8 Feed
3-Chloro-2-methylpropene 563-47-3 2 4 Gavage
C.l. Pigment red 23 6471-49-4 2 0 Feed
C.l. Pigment red 3 2425-85-6 2 4se Feed
C.l. Acid red 114 6459-94-5 2 (11) Water
C.l. Solventyellow 14 842-07-9 7 2 Feed
C.l. Disperse yellow3 2832-40-8 + 1 2se Feed
C.l. Basic red 9 569-61-9 2 11 Feed
D & C Red No. 9 5160-02-1 1 2 Feed
p,p-Ethyl DDD (ierthane) 72-56-0 1 0 Feed
2,4-Diaminophenol dihydrochloride 137-09-7 + 2 lse Gavage
Dimethylvinylchloride 513-37-1 2 11 Gavage
2,4-dinitrotoluene 121-14-2 2 2se Feed
1,3-dichloropropene (Telone II) 542-75-6 2 6 Gavage
Dioxathion 78-34-2 1 0 Feed
Ethyl bromide (bromoethane) 74-96-4 2 2 Inhalation
Formulated fenaminosulf 140-56-7 2 0 Feed
HC Blue 2 33229-34-4 2 0 Feed
HC Yellow4 59820-43-8 2 0 Feed
lodoform 75-47-8 2 0 Gavage
Lead dimethyldithiocarbamate 19010-66-3 3 0 Feed
Methylene chloride 75-09-2 2 6 Inhalation
Methyl parathion 298-00-0 1 0 Feed
Nithiazide 139-94-6 1 3 Feed
4-Nitro-o-phenylenediamine 99-56-9 2 0 Feed
5-Nitro-o-anisidine 99-59-2 2 4 Feed
3-Nitro-p-acetophenetide 1777-84-0 2 1 Feed
Nitrofen 1836-75-5 1 2 Feed
Pentachloroanisole 1825-21-4 2 3se Gavage
Photodieldrin 13366-73-9 2 0 Feed
2,4 and 2,5-Toluenediisocyanate 26471-62-5 + 1 8 Gavage
Tribromomethane 75-25-2 2 2 Gavoge
Trifluralin 1582-09-8 1 3 Feed
Abbreviations: SAL, Ames Salmonella mutagenesis assay; CHO, Chinese hamster ovary cell assay for chro-
mosomal abnormalities; CAS, Chemical Abstracts Registry number; CS, contact sensitization.
aRFB-primary rationale for the bioassay as follows: 1, widespread use; 2, structural relation with known
carcinogen or mutagen; 3, inadequate previous study; 4, representative of a structural class; 5, drug with
prolonged exposure; 6, potential use as an antineoplastic drug; 7, preexisting evidence of carcinogenicity;
and 8, potential warfare agent.
"Tumor score is the number of different organs that showed tumor induction in mice and rats of both sexes;
parentheses indicate the number oftumorsitesthatwere obtained onlyon a single species; se-tumor responses
indicate thosethatwere classified as some evidence in contrasttothe strongerdesignation ofclearevidence.
response to each chemical in Tables 1-4 was
the sum of the number of organs that had
statistically significant tumor induction
across all four test groups; this is called the
tumor score. Thus, if the liver were the only
organ with statistically significant tumor
induction by a given chemical, and this
occurred in male and female rats and mice,
the tumor score for that chemical would be
4. If four different organs in female mice
were involved in tumor induction and none
of the three other groups showed a tumor
response, the tumor score for that chemical
would also be 4; this illustration is an
extreme example ofa non-uniform response,
which in fact did not occur. The tumor score
for each chemical was a measure of the per-
vasiveness oftumor induction with respect to
sex, organ, and species. It was not a measure
of potency in the sense of the daily dosage
required to induce a given level of tumori-
genic response. A zero score, ofcourse, indi-
cated a nontumorigenic response.
The terminology used in the technical
reports changed over the years. The earlier
reports used the terms positive or suggestive
evidence, either ofwhich we considered to
be a tumorigenic response. The later reports
used the terminology for the tumor bioassays
as clear evidence, some evidence, equivocal
evidence, or no evidence. We considered
either clear or some evidence as an indication
oftumorigenicity; the less decisive some evi-
dence responses are indicated in Tables 1-4.
The rationale for doing the bioassay was
obtained from each technical report. The
primary rationales are as follows: 1) wide-
spread usage; 2) structural resemblance to a
known carcinogen or mutagen; 3) an inade-
quate previous study; 4) representative of a
structural class that had not been adequately
studied; 5) a drugwhose use is prolonged; 6)
an antineoplastic drug; 7) preexisting evi-
denceofcarcinogenicity; and 8) potential use
as a warfare agent. The first two rationales
included 82% ofthe chemicals.
Table 5 summarizes the data from the
entire NTP bioassay sample with respect to
genotoxicity, contact sensitization, and
tumorigenicity, including the proportion of
some evidence tumor responses and the pri-
mary rationale for the decision to test the
chemical. All of the differences, except
where indicated, were statistically significant
in a two-tailed test atp = <0.05. There was a
total of 209 chemicals in the analysis,
including the known contact sensitizers and
those that were not known to be such. The
majority of the chemicals were SALP, i.e.,
122 (58%) compared to 87 (42%) that were
SAL-. In both the SAL+ and SAL- groups,
the majority ofchemicals were CHO+, 71%
and 74%, respectively.
The majority of the 209 tested chemi-
cals were tumorigens (64%). Somewhat
more of the SAL+ chemicals were tumori-
genic (74%), compared to the SAL- chemi-
cals (51%). The 90 SAL+ tumorigens were
more decisively tumorigenic in the sense
that only 12% were in the some evidence
category, compared to 34% for the 44
SAL- tumorigens.
Somewhat more of the 209 chemicals
were selected for bioassay because ofstruc-
tural resemblance to carcinogens or muta-
gens (Rationale 2; 47%), compared to
those that were tested solely because of
widespread use (Rationale 1; 35%). This
was not statistically significant at p = 0.05.
Comparing Rationales 1 and 2, the SAP
group was heavily weighted (2.5:1) toward
chemicals with structural resemblance to
carcinogens (Rationale 2), while the SAL-
chemicals were heavily weighted (3.2:1)
toward those that were selected because of
widespread exposure (Rationale 1).
Of the 209 chemicals, there were 36
(17%) that were contact sensitizers for
humans. Table 6 summarizes the data
from the 36 contact sensitizing chemicals
for the same parameters as those shown in
Table 5 for the total sample of209 chemi-
cals. About two-thirds (63%) of the con-
tact sensitizers were in the SAL- category.
This differs from the bioassay population
as a whole, in which 42% were SAL-. The
same high proportion of both SAL- and
SAL+ chemicals (80%) were CHO+ as in
the entire bioassay sample (72%). As with
the total sample ofbioassay chemicals, the
majority of the SAL+ sensitizers (55%)
were tested because of structural resem-
blance to carcinogens and mutagens
(Rationale 2), and most (80%) ofthe SAL-
sensitizers were bioassayed because of
widespread usage (Rationale 1). About half
(54%) of the contact sensitizers were
tumorigenic; a larger proportion of the
SAL+ contact sensitizers were tumorigenic
(77%) compared to the SAL sensitizers
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(41%). A larger proportion (44%) of the
SAL- tumorigens were in the some evi-
dence category compared with 20% in the
SAL+ sensitizer carcinogen group. Thus the
contact sensitizers differed from the total
sample of bioassay chemicals in only two
respects: the rationale for selection was dif-
ferent and there was a greater proportion
of SAL- chemicals among the contact sen-
sitizers.
Table 7 shows the frequency distribution
of the tumor scores, i.e., the number of
organs in which tumors were induced, as
described above according to theAmes assay,
for the total NTP sample and for contact
sensitizers alone, without regard to the route
of administration. The frequency distribu-
tions were biased toward the low tumor
scores and were analyzed as log distributions.
In the total NTP sample, the SAL+ chemicals
had about twice the tumor score as the SAL-
chemicals, with a geometric mean and geo-
metric standard deviation of 2.1 ± 2.3 and
0.9 ± 2.0, respectively. This was statistically,
significant (p20.0001). The SAL+ contact
sensitizers also had a higher geometric mean
tumor score than the SAL- contact sensitiz-
ers, 1.3 ± 1.9 compared to 0.8 ± 2.1, but the
difference was not statistically significant (p =
0.3). There were no blockbuster chemicals in
anygroup except the SAL+, CHO+ group, in
which 1,2-dibromoethane, 2,3-dibromo-1-
propanol, glycidyl, and 1,2,3-trichloro-
propane had tumor scores of 15, 23, 25, and
19, respectively. There were a few SAL+ con-
tact sensitizers that had substantial tumor
scores such as coumarin (9), and 2,4-toluene
diisocyanate (9). Among the SAL- contact
sensitizers, only N-methylolacrylamide and
2-mercaptobenzothiazole had substantial
tumor scores of7and 6, respectively.
As indicated above, the characterization
of tumor responses as tumor scores was a
measure ofthe pervasiveness ofthe tumori-
genic action across species, organs, and sex.
Potency was characterized, with respect to
genotoxicity, on the basis of the dosage
(milligrams per kilogram per day) estimat-
ed to produce a 50% tumor incidence
(TD50) using published values (10) for
many of the same chemicals that were
included in this analysis but necessarily
excluding those which were nontumori-
genic. There were no statistically significant
differences according to genotoxicity; this
could hardly be otherwise because the
range of potencies was enormous, as
reflected by the extremes where the differ-
ence was a factor of109.
There appeared to be a difference,
according to genotoxicity, in the organs in
which tumors were induced in both the
total NTP sample and the contact sensitiz-
ers. The organs were stratified according to
Table 3. SAL-,CHO+ NTP compounds
Chemical
Acetominophen (4-hydroxyacetanilide)
Allyl isothiocyanate
Allyl isovalerate
Anthranilic acid
Benzyl alcohol
Gamma-butyrolactone
Carbromol
D-Carvone
Chlorinated paraffins: C12, (60% chlorine)
2-Chloroacetophenone (CN)
3-Chloro-2-methylpropene
Chlorothalonil
4-Chloro-o-toluidine hydrochloride
Chloropheniramine maleate
C.l. Acid orange 10
Diallyl phthalate
Dibutyltin diacetate
Di(2-ethylhexyl) adipate
N,N-dimethylaniline
Dimethyl morpholinophosphoramidate
Diphenhydramine hydrochloride
Ethyl acrylate
Eugenol
Furan
Furfural
Furosemide
Heptachlor
Hexachlorocyclopentadiene
Hydroquinone
Malathion
Manganese sulfate monohydrate
2-Mercaptobenzothiazole
Mercuric chloride
x-Methylbenzyl alcohol
Methyl methacrylate
N-methylolacrylamide
Methylphenidate hydrochloride
Monuron
Naphthalene
p-Nitrophenol
P-nitrostyrene
Pentachloronitrobenzene
Pentachlorophenol, technical
Phenol
Phenylbutazone
N-phenyl-p-phenylenediamine
1-Phenyl-2-thiourea
Picloram
Polysorbate 80 (glycol)
Propyl gallate
Pyrimethamine
Resorcinol
Rhodamine 6G
Sodium fluoride
Stannous chloride
4,4'-Sulfonyidianaline (dapsone)
Tetraethylthiuram disufide
Tetrakis (hydroxymethyl) phosphonium chloride
Tetrakis (hydroxymethyl) phosphonium sulfide
1,1,1-Trichloroethane
1,1,2-Trichloroethane
Turmeric oleoresin (curcumin)
2,6-Xylidine
Zearalenone
CAS
103-90-2
57-06-7
2835-39-4
118-92-3
100-51-6
96-48-0
77-65-6
2244-16-8
63449-39-8
532-27-4
563-47-3
1897-45-64
3165-93-3
113-92-8
1936-15-8
131-17-9
1067-33-0
103-23-1
121-69-7
597-25-1
147-24-0
140-88-5
97-53-0
110-00-9
98-01-1
54-31-9
76-44-8
77-47-4
123-31-9
121-75-5
10034-96-5
149-30-4
7487-94-7
98-85-1
80-62-6
924-42-5
298-59-9
150-68-5
91-20-3
100-02-7
102-96-5
82-68-8
87-86-5
108-95-2
50-33-9
101-54-2
103-85-5
1918-02-1
9005-65-6
121-79-9
58-14-0
108-46-3
989-38-8
7681-49-4
7772-99-8
80-08-0
97-77-8
124-64-1
55566-30-8
71-55-6
79-00-5
8024-37-1
87-62-7
17924-92-4
CS RFBa
1
+ 1
4
2
l
4
2
2
2
l
l
l
4
+ 2
8
+ 1
+ 1
+ 2 1
1
2
+ 1
+ 1
3
+ 4
+ 1
2
+ 2
+ 2
5
3
2
1
1
+ 3
+ 1
5
+ 1
2
2
2
5
1
5
2
2
1
1
1
1
2
Tumor
scoreb
0
2
0
0
0
0
(0)
7
0
4
2
2
0
0
0
0
2
lse
2se
0
3
0
8
3
lse
2
0
3se
0
0
6se
lse
lse
0
7
2se
2
M1se
0
0
(0)
(9)
0
2se
0
0
lse
0
0
0
0
0
0
0
0
0
0
0
2
0
(4)
3
Route
Feed
Gavage
Gavage
Feed
Gavage
Gavage
Feed
Gavage
Gavage
Inhalation
Gavage
Feed
Feed
Gavage
Feed
Gavage
Feed
Feed
Gavage
Gavage
Feed
Gavage
Feed
Gavage
Gavage
Feed
Feed
Inhalation
Gavage
Feed
Feed
Gavage
Gavage
Gavage
Inhalation
Gavage
Feed
Feed
Inhalation
Dermal
Gavage
Feed
Feed
Water
Gavage
Feed
Feed
Feed
Feed
Feed
Feed
Gavage
Feed
Water
Feed
Feed
Feed
Feed
Feed
Gavage
Gavage
Feed
Feed
Feed
Abbreviations: SAL, Ames Salmonella mutagenesis assay; CHO, Chinese hamster ovary cell assay for chro-
mosomal abnormalities; CAS, Chemical Abstracts Registry number; CS, contactsensitization.
aRFB primary rationale for the bioassay as follows: 1, widespread use; 2, structural relation with known
carcinogen or mutagen; 3, inadequate previous study; 4, representative of a structural class; 5, drug with pro-
longed exposure; 6, potential use as an antineoplastic drug; 7, preexisting evidence of carcinogenicity; and 8,
potential warfare agent.
Tumor score is the number of different organs that showed tumor induction in mice and rats of both sexes;
parentheses indicate the number of tumor sites that were obtained only on a single species; se-tumor
responses indicate those that were classified as some evidence in contrast to the stronger designation of
clear evidence.
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parenchymal organs included the various
tumors of the kidney, liver, endocrine
glands, and the hemopoietic and lymphatic
tissues. Table 8 presents the tumor scores
for the indicated organs together with the
corresponding percentage of the aggregate
tumor scores for genotoxic and nongeno-
toxic chemicals. For example, the tumor
score for the bladder among SAL+ chemi-
cals was 20, which was 5% ofthe aggregate
tumor score of 389 for the SAL+ chemicals
in the total NTP sample; the combined
Table 4. SAL-,CHO- NTP compounds
Chemical CAS CS RFBa Tumorscoreb Route
11-Aminoundecanoic acid 2432-99-7 1 1 Feed
Benzoin 119-53-9 + 1 0 Feed
Benzyl acetate 140-11-4 1 5 Gavage
Calcium cyanamide 156-62-7 3 0 Feed
Chloroform 67-66-3 2 3 Gavage
Cinnamyl anthranilate 87-29-6 3 4 Feed
p-Dichlorobenzene 106-46-7 + 1 3 Gavage
1,2-Dichlorobenzene 95-50-1 + 1 0 Gavage
Di(2-ethylhexyl) phthalate 117-81-7 + 1 4 Feed
5,5-Diphenylhydantoin 57-41-0 5 1 Feed
Ethylene thiourea 96-45-7 1 8 Feed
Fenthion 55-38-9 1 Ise Feed
FD&C Yellow No. 6 2783-94-0 1 0 Feed
Isophorone 78-59-1 1 2se Gavage
Maloxon 1634-76-2 1 0 Feed
Parathion 56-38-2 + 1 2se Feed
Pentachloroethane 76-01-7 2 2 Gavage
Sulfisoxazole 127-69-5 5 0 Gavage
2,3,7,8-Tetrachlorodibenzo-
p-dioxin 1746-01-6 1 5 Gavage
Titanium dioxide 13463-67-7 1 0 Feed
Trichloroethylene 79-01-6 2 (2) Gavage
Tetrachloroethylene 127-18-4 2 5 Inhalation
Tris(2-ethylhexyl) phosphate 78-48-2 1 lse Gavage
Abbreviations: SAL, Ames Salmonella mutagenesis assay; CHO, Chinese hamster ovary cell assay for
chromosomal abnormalities; CAS, Chemical Abstracts Registry number; CS, contact sensitization.
aRFB-primary rationale for the bioassay as follows: 1, widespread use; 2, structural relation with known
carcinogen or mutagen; 3, inadequate previous study; 4, representative of a structural class; 5, drug with
prolonged exposure; 6, potential use as an antineoplastic drug; 7, preexisting evidence of carcinogenicity;
and 8, potential warfare agent.
bTumor score is the number of different organs that showed tumor induction in mice and rats of both
sexes; parentheses indicate the number of tumor sites that were obtained only on a single species; se-
tumor responses indicate those that were classified as some evidence in contrast to the stronger desig-
nation of clear evidence.
subtotals are less than the aggregate totals
because 14% of the tumors occurred in
small numbers in miscellaneous organs and
were not included in the analysis. This is
true also for the SAL- chemicals in the total
NTP sample and the contact sensitizers of
both genotoxicity types. There was a
predilection of SAL- chemicals for tumor
induction in parenchymal tissues; i.e., 76%
of tumors in the SAL- group were in
parenchymal organs compared to 15% in
epithelial organs; this was statistically signif-
icant at p<O.05. In contrast, there was a
roughly equal distribution ofepithelial and
parenchymal organ sites among the SAL+
chemicals. Similarly, among the epithelial
organ sites of tumor formation, there was
approximately a threefold larger proportion
ofSAL+chemicals (49%) compared to SAL
chemicals (15%), whereas the opposite rela-
tionship was true for the parenchymal
organs (37% and 76%, respectively). These
comparisons were also statistically signifi-
cant at p.O.O5. Roughly the same pattern
was observed with the contact sensitizers as
with the NTP sample as a whole, but with-
out statistical significance. The much larger
aggregate tumor score for the SAL+ chemi-
cals (389), compared to the SAL- chemicals
(115) was due to the larger number ofSAL+
chemicals, the higher proportion of tumor-
responding animals, and the larger number
oforgans in which tumors were induced.
The relative inability of SAL- chemicals
to induce tumors in epithelial tissues raises
the question ofwhether this might be due
to differences in background tumor rates;
i.e., if nongenotoxic chemicals are only
tumor promoters and tumor promoters act
by accelerating tumorigenic processes that
are under way, they would be expected to
have a predilection for organ sites with rela-
tively high background tumor rates. There
was a correlation between tumor induction
and background tumor rates in the sense
that, when a chemical produced a larger
Table 5. Various characteristics ofthetotal NTP bioassay sample according to patterns of genotoxicity
SAL+,CHO+ SAL+,CHO- SAL+ SAL-,CHO+ SAL-,CHO- SAL- Total
Genotoxicity Number Percent Number Percent Number Percent Number Percent Number Percent Number Percent Number Percent
Chemicals (n) 87 (100) 35 (100) 122 (100) 64 (100) 23 (100) 87 (100) 209 (100)
42-> 17-> 58-> 31 - 11-> 42->
Tumorigens 67 771 24 69T 91 751 29 45T 16 701 45 521 136 651
50-> 17-> 67-> 21- 12-> 33->
Tumorigens, 06 09T 05 21T 11 12T 11 38T 04 251 15 331 26 191
some evidencea 23-> 19-> 42-> 42-> 15-> 58->
Rationale 1 12 14T 09 261 21 17T 37 58T 15 65T 52 601 73 351
16-> 12-> 29-> 51-> 21-> 71->
Rationale 2 58 671 24 69T 82 671 14 22T 04 171 18 211 100 48T
58-> 24-> 82-> 14-> 04-> 18->
Other 17 201 02 06T 19 161 13 20T 04 171 17 201 36 171
rationale 47-> 06-> 53-> 36-> 11 -> 47->
Abbreviations: SAL, Ames Salmonella mutagenesis assay; CHO, Chinese hamster ovary cell assay for chromosomal abnormalties. Each vertical arrow refers to
the percentage ofthe number atthe top ofthe same column. Each horizontal arrow refers to the percentage ofthe number in the right hand box in the same row.
aPercentage oftumorigens that show some evidence.
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whether the tumors arose partially or entire-
ly from epithelial lining or surface (mucos-
al) cells or mainly from parenchymal cells.
The organs where tumors derived, at least
partly, from lining epithelium included the
mucosa of the bladder, the bronchial and
nasal mucosae, the lining of the gastroin-
testinal tract from the mouth through the
intestines, the skin and adnexal structures,
the sebaceous gland of the ear canal
(Zymbal gland), and the epithelia of the
breast and clitoral and preputial glands. The
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Table 6. Characteristics ofthe contact sensitizers with respectto patterns of genotoxicity
SAL+,CHO+ SAL+,CHO- SAL+ SAL-,CHO+ SAL-,CHO- SAL- Total
Genotoxicity Number Percent Number Number Percent Number Percent Number Number Percent Number Percent
Chemicals (n) 10 (100) 03 13 (100) 18 (100) 05 23 (100) 36 (100)
36-> 64-> (100)
Tumorigens 07 701 03 10 771 07 391 03 10 43T 20 561
50-> 50-> (100)
Tumorigens, 01 141 02 03 301 04 57T 01 05 501 08 401
some evidencea 37-> 63-> (100)
Rationale 1 02 20T 02 04 31T 11 611 05 16 701 20 561
20-> 80-> (100)
Rationale 2 06 601 0 06 461 05 281 0 05 221 11 311
55--> 45-> (100)
Abbreviations: SAL, Ames Salmonella mutagenesis assay; CHO, Chinese hamster ovary cell assay for chromosomal abnormalties. Each vertical arrow refers to
the percentage ofthe number atthe top ofthe same column. Each horizontal arrow refers to the percentage ofthe number in the right hand box in the same row.
aPercentage oftumorigens that show some evidence.
tumor response in a given organ in one
species compared to another, the back-
ground tumor rate was generally higher in
the organ of the species with the higher
tumor response. Table 9 compares the
background tumor rates in various organs
ofrats and mice (11) with the tumor scores
for individual organs for the 209 chemicals
in the total NTP samples. Only those
organs that had a minimum tumor score of
5 are included in the table. For example, in
Table 9, the tumor scores for the rat and
mouse livers were 45 and 99, respectively,
and the corresponding background rates for
males and females combined were 4 and
62%, respectively, showing a concordance
between the species predominance of liver
tumor induction and background tumor
rates. Of the 20 organ comparisons, 15
(75%) showed a concordance between the
higher species response and the higher
background tumor incidence.
While there is an association of back-
ground tumor rates and species responses,
some of the organs that had epithelial
tumors also had high background tumor
rates that were not enhanced by SAL-
chemicals, such as the lung in mice and the
mammary gland in rats. Hence the expla-
nation for the differences in organ patterns
of tumor formation according to genotoxi-
city is not likely to be simple.
To evaluate the frequency ofoccurrence
of contact sensitizers among chemicals in
general, we searched the 10,000 entries in
the Merck Index (12) for contact sensitizers.
We made four passes through the chemicals
by taking every hundredth chemical and
comparing it to the list ofcontact sensitizers
used above, starting with 1, 101, 1001,
9901; 20, 120, 1020, 9920; 50, 150, 1050,
9950; and 70, 170, 1070, 9970. In each of
the four passes ofabout 100 chemicals each,
we identified 4,4,2, and 2 contact sensitiz-
ers, respectively, for an average frequency of
3% [standard deviation (SD) = 1%].
Table 7. The number and percent (in parentheses) of bioassay chemicals that induced tumors in the indi-
cated number of organs (tumor scores) according to genotoxicityforthe total NTP bioassay sample and for
the contactsensitizers alone
Total NTP bioassays Contact sensitizers
Tumor scores SAL+ SAL- SAL+ SAL-
0 30 (26) 40 (49) 3(23) 12 (57)
1-3 43(37) 30(37) 8(62) 6(29)
4-9 34(29) 11 (14) 2(15) 3(14)
>10 9 (8) 0 (0) 0(0) 0(0)
Chemicals 116 (100) 81 (100) 13(100) 21 (100)
Geometric mean (SD)a 2.1 (2.3) 0.9 (2.0) 1.3 1.9) 0.8 (2.1)
SAL, Ames Salmonella assay. All bioassays used were done on both rats and mice.
aSD is geometric standard deviation.
Table 8. Tumor induction sites, according to genotoxicity
Total NTP sample Contact sensitizers
Organs SAL+ SAL- SAL+ SAL-
Organs in which tumors arose in part or
entirelyfrom epithelial cells
Bladder 20(5) 2 (2) 2 (10) 0 (0)
Lung/nose 46(12) 4(3) 3 (14) 2(7)
Gastrointestinala 63(16) 8(7) 1(5) 2(7)
Skin/zymbal 40(10) 0 (0) 0(0) 0(0)
Reproductiveb 25(6) 3(3) 1 (5) 0 (0)
Subtotal 194(49) 17(15) 7(34) 4(14)
Organs in which tumors arose mainlyfrom
parenchymal cells
Kidney 9(2) 10(9) 2(10) 2(7)
Leukemia/lymphoma 16 (4) 8 (7) 0 (0) 2(7)
Liver 92(24) 51(44) 6(29) 11(38)
Endocrinec 28(7) 18(16) 2(10) 4(14)
Subtotal 145 (37) 87(76) 10(49) 19(66)
Aggregate tumorscoresd 389 (86) 115(91) 21(83) 29(80)
SAL, Ames Salmonella assay. Values shown are tumor score for the indicated organ, with the proportion
ofthe total tumor score shown in parentheses.
aincludes oral,tongue, esophagus, stomach, and intestine.
bincludes mammary, clitoral, and preputial glands.
clncludes thyroid, adrenal, and pituitary.
dThe aggregate percentage is less than 100% because miscellaneous organs in which small numbers of
tumors occurred were not included in the analysis.
Discussion
Summarizing the above findings, it can be
said that of the 209 bioassayed chemicals
included in this analysis, 36 were known to
be human contact sensitizers (17%). The
contact sensitizers differed from the NTP
bioassay group as a whole in that a larger
proportion were nongenotoxic, which was
probably related to the fact that fewer of
them were selected for bioassay on the basis
of their structural resemblance to known
carcinogens, in contrast to widespread
usage. When sorted for genotoxicity, the
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Table 9. Comparison of rats and mice of both sexes in terms ofthe tumor scores in the indicated organs in
relation to the background tumor rates
Background tumor
Tumor scores incidence (%)a
Organs Rat Mouse Rat Mouse Concordance
Bladder* 18 4 0.6 0.6 No
Kidney * 20 1 1.0 0.5 Yes
Leukemia* 17 2 77 0.1 Yes
Lymphoma 2 3 1 34 No
Oral/esophagus* 11 1 1.9 0.1 Yes
Forestomach 28 23 0.3 3.3 No
Intestine* 10 0 0.6 1.4 No
Liver* 45 99 4 62 Yes
Pancreas* 7 0 1.9 0.1 Yes
Thyroid 17 13 31 4 Yes
Adrenal 12 8 38 6 Yes
Pituitary* 1 6 83 16 No
Vascular* 2 11 1 10 Yes
Sarcoma (all) 11 6 10 9 No
Skin epidermal and adnexa* 19 6 7 0.3 Yes
Zymbal* 18 1 1.5 0.1 Yes
Mammary* 16 4 48 1.3 Yes
Ovary 0 2 1.0 1.0 No
Uterus 3 4 14 3 No
Clitoral/preputial* 11 1 22 0.1 Yes
Nose* 14 6 0.8 0.1 Yes
Lung* 8 23 5 28 Yes
Harderian gland* 2 10 0 9 Yes
Total tumor score 286 234
Number ofanimals 198 195
aBackground incidences ofthe sexes is summed.
*Difference between rat and mouse tumor responses are statistically significant(p.0.05).
contact sensitizers had about the same
characteristics as the total population of
bioassayed chemicals in the following
respects: 1) roughly the same proportion
were tumorigenic; 2) proportionately more
of the SAL+ chemicals were tumorigenic
than those that were SAL-; 3) the SAL-
tumorigens had a greater proportion ofless
decisive (some evidence) tumor responses
than the SAP tumorigens; 4) the tumor
scores were greater in the SAL+ chemicals
than in the SAL- chemicals; and 5) the
SAL- chemicals had proportionately more
parenchymal tumors (renal, liver, and
endocrine tumors and leukemia) than the
SAL+ chemicals, whereas the latter pro-
duced relatively more epithelial tumors
[bladder, gastrointestinal, skin and zymbal
gland, breast, clitoral and preputial glands,
and respiratory tumors (nose and lung)].
Most of the chemicals were CHO+
regardless of whether they were SAL+ or
SAL- or whether they were carcinogens.
This may reflect the possibility that the
underlying reason why all ofthe chemicals
were chosen for bioassay, regardless of the
specific rationale, was because they were
highly reactive as intermediates in chemical
synthesis or as reactive finished products;
perhaps highly reactive chemicals tend to
react with protein. This might mean that
many of the NTP bioassay chemicals are
contact sensitizers. If so, a comparison of
the characteristics ofthe contact sensitizers
to the total group ofbioassay chemicals has
the limitation that some substantial frac-
tion ofthe chemicals that were not known
to be contact sensitizers may actually be so.
The concentration ofcontact sensitizers
in the SAL- CHO+ category is unexplained.
The status of a chemical as CHO+ or
CHO- did not consistently affect tumori-
genicity. The SAL- CHO- group was
anomalous because of its high proportion
oftumorigens.
The similarity of the characteristics of
the contact sensitizers with those of the
entire NTP sample raises the issue of
whether contact sensitization might be
unrelated to tumorigenicity, i.e., selecting
for contact sensitizers constitutes a random
sample of bioassay chemicals. However,
contact sensitizers were not a random sam-
ple because of the differences in the ratio-
nale for selection; the properties ofthe con-
tact sensitizers and the total NTP sample
only matched when the two groups were
compared on the basis ofmutagenicity.
The connection between tumorigens
and contact sensitizers relates to the ability
ofboth classes ofchemicals to interact with
protein. The contact sensitizers react with
the amino acid side chains ofproteins by a
variety of mechanisms: two electron reac-
tions, including nucleophilic and elec-
trophilic substitutions and additions, as
well as single electron (free radical) addi-
tions (2). Genotoxic tumorigens, as elec-
trophiles, undergo the same kinds ofinter-
actions with proteins as contact sensitizers,
but in the case of genotoxic tumorigens,
the electrophilic interactions extend to
DNA. There are subtle differences in
chemical reactivity that depend on the
strength of the electrophilic and nucle-
ophilic centers, as well as the stearic prop-
erties of these chemicals that affect the
amount and location of the adducts on
protein and DNA. Also, there are impor-
tant biological factors that have an effect
on the outcome of the chemical reactions
of carcinogens and contact sensitizers.
When an electrophile, a hapten in the con-
text ofACD, is adducted onto the amino
acid ofa protein, it may become an antigen
ifthe resultant complex has a structure that
is capable of sensitizing T lymphocytes;
this is a biological response that can have a
great deal of individual variability among
humans. When an electrophile is adducted
onto DNA, it may result in an oncogenic
mutation as a consequence of mistakes in
DNA repair processes. Hence, even though
there is a commonality in the chemical
behavior ofcontact sensitizers and genotox-
ic tumorigens as electrophiles, there are
strong chemical and biological factors that
can modulate their effects. However, there
is sufficient overlap between the actions of
contact sensitizers and tumorigens to raise
the possibility that when a chemical is
identified as a contact sensitizer, it has a
significant likelihood ofbeing a tumorigen.
ACD, caused by SAL- contact sensitiz-
ers, might be a useful biomarker for identi-
fying nongenotoxic tumor promoters.
SAL' contact sensitizers would be expected
to be both tumor promoters and initiators.
A possible common denominator between
contact sensitization and tumor promotion
might be the induction of inflammation.
ACD is an inflammatory reaction caused
by a complex immune response set off by
the chemical interaction of the sensitizer,
the haptene, with skin proteins. The resul-
tant complex, the antigen, ultimately sensi-
tizes T lymphocytes, which are drawn to
the site ofskin exposure where they induce
a Type IV cell-mediated inflammatory
reaction. Contact sensitization also occurs
in animals, and the inflammatory reaction
is indistinguishable from inflammation
produced by skin tumor promoters.
Inflammation is a characteristic of many
tumor promoters (13,14). Mechanistically,
the connection between inflammation and
tumor promotion is thought to involve the
production of free radicals (15,16). Some
tumor promoters are contact sensitizers,
including benzoyl peroxide (17), phorbol
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myristate acetate (1), and 2,4-dinitro-1-flu-
orobenzene (1) for mouse skin and butyl
hydroxytoluene for rat liver (18). The abili-
ty of tumorigens to induce inflammation
may be the basis for the promoting compo-
nent oftheir action; whether this is due to
an immune or irritant reaction is not
known (19).
The action ofcontact sensitizing tumori-
gens may be stimulated by the induction of
humoral immunity. For example, mice
injected with rabbit benzo(a)pyrene (BaP)
antibodies show a much enhanced skin
tumor response to BaP applied dermally
(20). Moreover, there is evidence that trans-
planted malignant cells grow faster in a host
that had been previously immunized against
them (21).
We examined the issue ofwhether con-
tact sensitizers are tumor promoters as a
consequence oftheir immunological effects
in a previous study that used a well-known
contact sensitizer and tumor promoter
(22,23), 1-fluoro 2,4-dinitrobenzene
(DNFB), in Tg.AC mouse skin. This
transgenic mouse is tumor initiated by the
presence of a mutated ras oncogene and is
therefore a model for skin tumor promo-
tion (24). The skin application of DNFB
produced the typical promotional response
ofsquamous papillomas, with an associated
dermal inflammatory reaction. However,
the immune-depressing corticosteroid fluo-
cinolone acetonide applied locally did not
reduce either the inflammation or the
tumor response, suggesting that some com-
ponent ofcytotoxicity, not immunogenici-
ty, caused both the inflammation and the
tumor promotion, namely, that contact
sensitization and tumor promotion may be
independent responses to electrophilic
chemicals (1).
Figure 1 illustrates some ofthe interrela-
tionships that might exist between elec-
trophilicity, macromolecular adduction, and
various biological responses. Two linkages of
electrophilicity are shown: DNA and pro-
tein adduction. DNA adduction is linked to
mutagenicity and thus to tumor initiation
and progression. Protein adduction is shown
to have a four-way linkage to cell-mediated
immunity (contact sensitization), humoral
immunity, cytotoxicity, and indirectly to
mutagenicity (e.g., possibly by interference
with DNA repair and chromosomal segrega-
tion). The immune and cytotoxic responses
are linked with inflammation and thus with
tumor promotion. Promotion ofatheroscle-
rotic lesions is included on the basis that
polycyclic aromatic hydrocarbon carcino-
gens like benzo(a)pyrene and 7,12 dimethyl-
benz(a)anthracene promote the develop-
ment ofaortic atheromata in chickens (25);
this finding was prompted by the evidence
Figure 1. Possible interrelationships between electrophilicity, macromolecular adduction, and various
biological responses.
that aortic atheromatous plaques in humans
have a tumorlike monoclonal origin (26).
The evidence for the existence of some of
these linkages is modest. However, Figure 1
does illustrate that the contact sensitizing
and carcinogenic properties of electrophilic
chemicals could be independent expressions
oftheir common underlying chemical (elec-
trophilic) reactions, i.e., that contact sensi-
tizers are not tumorigens on the basis of
their immunogenic effects but rather
because of some aspect of their toxicity. It
would be useful to know whether the
immune response of contact sensitizers
enhances tumorigenicity; if so, immuno-
genically responsive people might be at
increased tumorigenic risk.
Carcinogen-induced deletion of pro-
teins, vital to growth control, was a promi-
nent theory of cancer that stemmed from
early work on protein binding in the liver
by p-aminoazobenzene, a chemical that,
interestingly, is a contact sensitizer (27).
This theory was overshadowed by the dis-
covery of carcinogen-induced genotoxicity
and was relegated to an epigenetic role (3).
Perhaps the epigenetic role ofelectrophile-
induced protein damage is promotion of
genetic damage.
A combination of the Ames assay for
mutagenicity and an assay for contact sen-
sitization, as a screening tool, might be an
improvement in the detection efficiency for
environmental tumorigens over that from
the Ames assay alone because it would help
to uncover rodent tumorigens among the
SAL- chemicals. This is seen in an analysis
of the Rationale 1 chemicals (widespread
use without structural resemblance to
known carcinogens), the group that is
probably the most relevant to the generality
ofchemicals in the environment. Ofthe 73
Rationale 1 chemicals, 23 were SAL'
(32%); of these, 15 were tumorigens on
bioassay (65%) with an overall tumorigenic
detection efficiency of 21% (15/73). Of
the remaining 50 chemicals that were
SAL-, 16 (32%) were contact sensitizers; of
these, 7 (44%) were tumorigenic on bioas-
say for an overall detection efficiency of
14% (7/50). Thus, in this illustration, if a
contact sensitization bioassay followed the
Ames test, the yield of rodent tumorigens
among the 73 Category I chemicals would
rise from 15 to 22, a 43% increase because
of the inclusion of SAL- chemicals. An
evaluation of false negatives cannot be
made because the unknown proportion of
chemicals that are not recognized as con-
tact sensitizers, but might be if they were
tested. There would be little or no advan-
tage to combining the Ames assay with an
assay for contact sensitization when the
Ames test is positive because there is a sta-
tistically insignificant increase in the effi-
ciency of detecting tumorigens; i.e., 77%
compared to 65%.
The 3% of Merck Index chemicals that
are contact sensitizers contrasts with the
17% of chemicals in the NTP bioassay
series. The Merck chemicals were selected
because they were biologically related, and
the NTP chemicals were mostly reactive
industrial intermediates or compounds in
commercial use because of their pesticidal
toxicity. The proportion of the 60,000
chemicals in commercial use (28) that are
contact sensitizers ranges from 3% to 17%.
An average of 10%, for purposes ofestima-
tion, yields perhaps 6,000 contact sensitizers
in commercial use. If, as in this analysis of
the NTP experience, about halfofthe con-
tact sensitizers are tumorigenic in the rodent
bioassay, there would be about 3,000 chem-
icals in commerce that would have to be
taken seriously as possible tumorigens.
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Furthermore, it is likely that only a fraction
of contact sensitizers have been identified
because it is notoriously difficult to specify a
causal agent in most cases ofACD. Ifcon-
tact sensitizers induce tumors because of
protein interaction, independent of
immunogenicity, then the contact sensitiza-
tion per se might underestimate tumori-
genicity because only some protein adducts
induce an immunogenic response.
The finding that contact sensitization
might be a useful marker for nongenotoxic
tumorigens is necessarily preliminary,
because the identification of contact sensi-
tizers in the NTP bioassay series was a mat-
ter of happenstance. A more systematic
evaluation ofthe immune response to these
NTP chemicals might provide a better defi-
nition ofthe utility ofcontact sensitization
as a screen for potential nongenotoxic envi-
ronmental tumorigens. An improved
understanding of the nature of the macro-
molecular interactions ofcontact sensitizers
might elucidate why some of these elec-
trophiles are protein interactive but
nongenotoxic; also, a better understanding
of the chemical mechanisms might lead to
an in vitro test that is more relevant to
tumorigenesis than contact sensitization.
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